Jubilant Pharmova | JUBLPHARMA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
60,06375,57891,10891,54461,162
Cost of revenue
Cost of revenue
-19,995-28,688-35,218-31,406-15,360
Gross Profit
Gross Profit
40,068
46,890
55,890
60,138
45,802
Sales, general & ad...
Sales, general and administrative
-25,166-31,307-38,500-40,668-31,661
Depreciation
Depreciation and amortization
-2,914-4,150-3,709-4,619-3,489
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
-1,449-400000
Operating income
Operating income EBIT
10,539
11,033
13,681
14,851
10,652
 
      
Profit before tax
Profit before tax
7,3768,5919,03812,1058,598
Net Income
Net income
5,757
6,428
5,745
8,982
8,359
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
36.93
41.25
36.86
56.39
52.48